Application of Sustained-release Carrier of NanoAg-Epidermal Growth Factor in Promoting Refractory Diabetic Wound Healing

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|13|2|135-140

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.13, Iss.2, 2016-02, pp. : 135-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Drug Delivery Via Human Epidermal Growth Factor Receptor for Sustained Release of Allyl Isothiocyanate

By  

Current Topics in Medicinal Chemistry, Vol. 18, Iss. 14, 2018-05 ,pp. : 1252-1260

Bentham Science Publishers

Access to resources Recommend Favorite

Triamcinolone and Intraocular Sustained-Release Delivery Systems in Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 337-346

Bentham Science Publishers

Access to resources Recommend Favorite

Transforming growth factor- 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment

By Holland T.A.   Tessmar J.K.V.   Tabata Y.   Mikos A.G.  

Journal of Controlled Release, Vol. 94, Iss. 1, 2004-01 ,pp. : 101-114

Elsevier

Access to resources Recommend Favorite

Wound healing acceleration of a novel transforming growth factor- inducer, SEK-1005

By Abe Y.   Inagaki K.   Fujiwara A.   Kuriyama K.  

European Journal of Pharmacology, Vol. 408, Iss. 2, 2000-11 ,pp. : 213-218

Elsevier

Access to resources Recommend Favorite

Nanotechnology and Diabetic Wound Healing: A Review

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 2, 2017-09 ,pp. : 87-95

Bentham Science Publishers

Access to resources Recommend Favorite